A once-daily GLP-1/GIP/glucagon receptor tri-agonist (NN1706) lowers body weight in rodents, monkeys and humans by Brian Finan, Jonathan D. Douros, Ronald Goldwater, Ann Maria Kruse Hansen, Julie B. Hjerpsted, Karina Rahr Hjøllund, Martin K. Kankam, Patrick J. Knerr, Anish Konkar, Stephanie A. Mowery, Timo D. Müller, John Rømer Nielsen, Sune Boris Nygård, Diego Perez-Tilve, Kirsten Raun, Bin Yang, Matthias H. Tschöp, Richard D. DiMarchi

Get full text

Glucose-dependent insulinotropic polypeptide (GIP) by Timo D. Müller, Alice Adriaenssens, Bo Ahrén, Matthias Blüher, Andreas L. Birkenfeld, Jonathan E. Campbell, Matthew P. Coghlan, David D'Alessio, Carolyn F. Deacon, Stefano DelPrato, Jonathan D. Douros, Daniel J. Drucker, Natalie S. Figueredo Burgos, Peter R. Flatt, Brian Finan, Ruth E. Gimeno, Fiona M. Gribble, Matthew R. Hayes, Christian Hölscher, Jens J. Holst, Patrick J. Knerr, Filip K. Knop, Christine M. Kusminski, Arkadiusz Liskiewicz, Guillaume Mabilleau, Stephanie A. Mowery, Michael A. Nauck, Aaron Novikoff, Frank Reimann, Anna G. Roberts, Mette M. Rosenkilde, Ricardo J. Samms, Philip E. Scherer, Randy J. Seeley, Kyle W. Sloop, Christian Wolfrum, Denise Wootten, Richard D. DiMarchi, Matthias H. Tschöp

Get full text